Davis Polk advised J.P. Morgan Securities Inc. and Jefferies & Company, Inc. as representatives of the several underwriters on the $85.5 million initial public offering of 4,500,000 shares of CafePress Inc. Of those shares, 2,500,000 shares are being sold by CafePress and 2,000,000 shares are being sold by selling stockholders. CafePress’ common stock is traded on the Nasdaq Global Select Market under the symbol “PRSS.”

Davis Polk advised OGX Austria GmbH, a subsidiary of OGX Petróleo e Gás Participações S.A. (OGX) on a Rule 144A/Regulation S high yield notes offering of $1.063 billion aggregate principal amount of 8.375% senior notes guaranteed by OGX and its subsidiaries OGX Petróleo e Gás Ltda. and OGX Campos Petróleo e Gás S.A.

Simpson Thacher represented Vanguard Health Systems, Inc. (“Vanguard”) in connection with the private placement offering, including registration rights for investors, of $375.0 million aggregate principal amount of 7.750% Senior Notes due 2019 issued by its wholly-owned subsidiaries, Vanguard Health Holding Company II, LLC (“VHS Holdco II”) and Vanguard Holding Company II, Inc. (together with VHS Holdco II, the “Issuers”), conducted in reliance on Rule 144A and Regulation S. The notes were issued as additional notes under an existing indenture, pursuant to which the Issuers issued $350 million aggregate principal amount of 7.750% Senior Notes due 2019 in January 2011. The Issuers intend to use the net proceeds from the offering for general corporate purposes, which may include, but not be limited to, working capital, capital expenditures, acquisitions, the repayment of any outstanding indebtedness under their existing revolving credit facility and to pay the fees and expenses incurred in connection with this offering.